Protara Therapeutics, Inc. (NASDAQ: TARA) reported Q1 EPS of ($0.97), $0.06 worse than the analyst estimate of ($0.91).

For earnings history and earnings-related data on Protara Therapeutics, Inc. (TARA) click here.